Vascular Endothelial Growth Factor-A, Matrix Metalloproteinase-1, and Macrophage Migration Inhibition Factor Changes in the Porcine Remnant Kidney Model: Evaluation by Magnetic Resonance Imaging

Journal of Vascular and Interventional Radiology

Volumn 21, Issue 7, 2010, Pages 1071-1077

  Misra, Sanjay ^a   Misra, Khamal D ^a   Glockner, James F ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; INTERSTITIAL COLLAGENASE; VASCULOTROPIN A;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; KIDNEY ARTERY EMBOLIZATION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY MASS; KIDNEY SCAR; MACROPHAGE MIGRATION INHIBITION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STAINING; SWINE; UREA NITROGEN BLOOD LEVEL; WESTERN BLOTTING;

ANIMALS; CHEMOTACTIC FACTORS; DISEASE MODELS, ANIMAL; EMBOLIZATION, THERAPEUTIC; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE IMAGING; MATRIX METALLOPROTEINASE 1; SWINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77954048345     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2010.01.047     Document Type: Article

References (37)

1. Coresh J., Selvin E., Stevens L.A., et al. Prevalence of chronic kidney disease in the United States. JAMA 298 (2007) 2038-2047
2. Gregg E.W., Cheng Y.J., Cadwell B.L., et al. Secular trends in cardiovascular disease risk factors according to body mass index in US adults. JAMA 293 (2005) 1868-1874
3. Mokdad A.H., Ford E.S., Bowman B.A., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 (2003) 76-79
4. Fields L.E., Burt V.L., Cutler J.A., Hughes J., Roccella E.J., and Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension 44 (2004) 398-404
5. Hajjar I., and Kotchen T.A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 290 (2003) 199-206
6. US Renal Data Systems. USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States (2007), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
7. Fogo A.B. Mechanisms of progression of chronic kidney disease. Pediatr Nephrol 22 (2007) 2011-2022
8. Lan H.Y., Bacher M., Yang N., et al. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med 185 (1997) 1455-1465
9. Bruchfeld A., Carrero J.J., Qureshi A.R., et al. Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation. Mol Med 15 (2009) 70-75
10. Ronco P., Lelongt B., Piedagnel R., and Chatziantoniou C. Matrix metalloproteinases in kidney disease progression and repair: a case of flipping the coin. Semin Nephrol 27 (2007) 352-362
11. Norman J.T., Gatti L., Wilson P.D., and Lewis M. Matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases expression by tubular epithelia and interstitial fibroblasts in the normal kidney and in fibrosis. Exp Nephrol 3 (1995) 88-89
12. Norman J.T., and Lewis M.P. Matrix metalloproteinases (MMPs) in renal fibrosis. Kidney Int Suppl 54 (1996) S61-S63
13. Johnson T.S., Haylor J.L., Thomas G.L., Fisher M., and El Nahas A.M. Matrix metalloproteinases and their inhibitions in experimental renal scarring. Exp Nephrol 10 (2002) 182-195
14. Ahmed A.K., Haylor J.L., El Nahas A.M., and Johnson T.S. Localization of matrix metalloproteinases and their inhibitors in experimental progressive kidney scarring. Kidney Int 71 (2007) 755-763
15. Schrijvers B.F., Flyvbjerg A., and De Vriese A.S. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 65 (2004) 2003-2017
16. Mu W., Long D.A., Ouyang X., et al. Angiostatin overexpression is associated with an improvement in chronic kidney injury by an anti-inflammatory mechanism. Am J Physiol Renal Physiol 296 (2009) F145-F152
17. Heifets M., Morrissey J.J., Purkerson M.L., Morrison A.R., and Klahr S. Effect of dietary lipids on renal function in rats with subtotal nephrectomy. Kidney Int 32 (1987) 335-341
18. Sigmon D.H., Gonzalez-Feldman E., Cavasin M.A., Potter D.L., and Beierwaltes W.H. Role of nitric oxide in the renal hemodynamic response to unilateral nephrectomy. J Am Soc Nephrol 15 (2004) 1413-1420
19. Kren S., and Hostetter T.H. The course of the remnant kidney model in mice. Kidney Int 56 (1999) 333-337
20. Fine L.G., Schlondorff D., Trizna W., Gilbert R.M., and Bricker N.S. Functional profile of the isolated uremic nephron. Impaired water permeability and adenylate cyclase responsiveness of the cortical collecting tubule to vasopressin. J Clin Invest 61 (1978) 1519-1527
21. Fine L.G., Trizna W., Bourgoignie J.J., and Bricker N.S. Functional profile of the isolated uremic nephron. Role of compensatory hypertrophy in the control of fluid reabsorption by the proximal straight tubule. The Journal of clinical investigation 61 (1978) 1508-1518
22. Fine L.G., Yanagawa N., Schultze R.G., Tuck M., and Trizna W. Functional profile of the isolated uremic nephron: potassium adaptation in the rabbit cortical collecting tubule. J Clin Invest 64 (1979) 1033-1043
23. Adams L.G., Polzin D.J., Osborne C.A., O'Brien T.D., and Hostetter T.H. Influence of dietary protein/calorie intake on renal morphology and function in cats with 5/6 nephrectomy. Lab Invest 70 (1994) 347-357
24. Bourgoignie J.J., Gavellas G., Martinez E., and Pardo V. Glomerular function and morphology after renal mass reduction in dogs. J Lab Clin Med 109 (1987) 380-388
25. Brown S.A., and Navar L.G. Single-nephron responses to systemic administration of amino acids in dogs. Am J Physiol 259 (1990) F739-F746
26. Bourgoignie J.J., Gavellas G., Sabnis S.G., and Antonovych T.T. Effect of protein diets on the renal function of baboons (Papio hamadryas) with remnant kidneys: a 5-year follow-up. Am J Kidney Dis 23 (1994) 199-204
27. Misra S., Gordon J.D., Fu A.A., et al. The Porcine Remnant Kidney Model of chronic renal insufficiency. J Surg Res 135 (2006) 370-379
28. Wilasrusmee C., Botash R., Da Silva M., et al. Initial angiogenic response in reduced renal mass after transplantation. J Surg Res 115 (2003) 63-68
29. Committee on care and use of laboratory animals of the institute of laboratory animal resources (1996), Government print office, Washington, DC
30. Misra S., Doherty M.G., Woodrum D., et al. Adventitial remodeling with increased matrix metalloproteinase-2 activity in a porcine arteriovenous polytetrafluoroethylene grafts. Kidney Int 68 (2005) 2890-2900
31. Misra S., Fu A.A., Puggioni A., et al. Increased shear stress with up regulation of VEGF-A and its receptors and MMP-2, MMP-9, and TIMP-1 in venous stenosis of hemodialysis grafts. Am J Physiol Heart Circ Physiol 294 (2008) H2219-H2230
32. Misra S., Fu A., Pugionni A., et al. Increased expression of Hypoxia inducible factor-1a in a porcine model of chronic renal insufficiency with arteriovenous polytetrafluoroethylene grafts. J Vasc Interv Radiol 19 (2008) 260-265
33. Misra S., Woodrum D., Homburger J., et al. Assessment of wall shear stress changes in arteries and veins of arteriovenous polytetrafluoroethylene grafts using magnetic resonance imaging. Cardiovasc Intervent Radiol 29 (2006) 624-629
34. Misra S., Lee N., Fu A., et al. Increased expression of a disintegrin and metalloproteinase thrombospondin-1 (ADAMTS-1) in thrombosed hemodialysis grafts. J Vasc Interv Radiol 19 (2009) 111-119
35. Miller P.L., Rennke H.G., and Meyer T.W. Hypertension and progressive glomerular injury caused by focal glomerular ischemia. Am J Physiol 259 (1990) F239-F245
36. Lenz O., Elliot S.J., and Stetler-Stevenson W.G. Matrix metalloproteinases in renal development and disease. J Am Soc Nephrol 11 (2000) 574-581
37. Schrijvers B.F., Flyvbjerg A., and De Vriese A.S. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int 65 (2004) 2003-2017